Explore how SmartBio Analytics has supported pharmaceutical and biotechnology organisations through tailored bioanalytical solutions, fast turnaround times and reliable analytical results.
A biotech company needed to initiate a preclinical PK/TK study in less than three weeks but had no validated method for their innovative small molecule.
Developed and qualified an LC/MS method in just 10 days, including optimization for sensitivity in plasma.
The client was able to start dosing on time, avoiding costly delays in their development plan.
An academic group required simultaneous quantification of over 15 steroid hormones as biomarkers in a cancer study, with high specificity to avoid cross-reactivity.
Designed and validated a multiplex LC/MS, ensuring robustness across different matrices.
Provided high-quality data within 5 days of sample receipt, enabling timely inclusion in a key grant submission.
A clinical CRO partner without internal LC/MS capacity needed rapid turnaround for >1,000 plasma samples in a generic drug bioequivalence trial.
Integrated seamlessly into the CRO’s workflow, applying an existing validated method from our Non-Proprietary Assays repository.
Delivered all results ahead of schedule, supporting a successful regulatory submission.
A pharmaceutical client developing a GalNAc-conjugated siRNA required biodistribution data in multiple tissues.
Developed and validated a sensitive LC/MS method for the intact oligonucleotide, optimizing extraction for different tissue types.
Generated data that informed lead candidate selection, shortening the preclinical decision-making process.
